Advertisement
Australia markets close in 1 hour 25 minutes
  • ALL ORDS

    7,859.10
    -72.90 (-0.92%)
     
  • ASX 200

    7,596.80
    -67.30 (-0.88%)
     
  • AUD/USD

    0.6471
    -0.0008 (-0.13%)
     
  • OIL

    81.12
    -0.81 (-0.99%)
     
  • GOLD

    2,294.90
    -8.00 (-0.35%)
     
  • Bitcoin AUD

    93,096.84
    -5,148.62 (-5.24%)
     
  • CMC Crypto 200

    1,289.20
    -49.86 (-3.72%)
     
  • AUD/EUR

    0.6071
    +0.0006 (+0.09%)
     
  • AUD/NZD

    1.0991
    +0.0000 (+0.00%)
     
  • NZX 50

    11,873.74
    -83.76 (-0.70%)
     
  • NASDAQ

    17,440.69
    -342.02 (-1.92%)
     
  • FTSE

    8,144.13
    -2.90 (-0.04%)
     
  • Dow Jones

    37,815.92
    -570.17 (-1.49%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • NIKKEI 225

    38,352.37
    -53.29 (-0.14%)
     

Is Scales Corporation Limited (NZSE:SCL) Worth NZ$3.2 Based On Its Intrinsic Value?

Key Insights

  • Scales' estimated fair value is NZ$2.39 based on Dividend Discount Model

  • Scales' NZ$3.21 share price signals that it might be 34% overvalued

  • Scales' peers are currently trading at a discount of 53% on average

How far off is Scales Corporation Limited (NZSE:SCL) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. There's really not all that much to it, even though it might appear quite complex.

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

ADVERTISEMENT

Check out our latest analysis for Scales

The Model

We have to calculate the value of Scales slightly differently to other stocks because it is a food company. In this approach dividends per share (DPS) are used, as free cash flow is difficult to estimate and often not reported by analysts. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. The 'Gordon Growth Model' is used, which simply assumes that dividend payments will continue to increase at a sustainable growth rate forever. The dividend is expected to grow at an annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.6%. We then discount this figure to today's value at a cost of equity of 6.2%. Relative to the current share price of NZ$3.2, the company appears reasonably expensive at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.

Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate)

= NZ$0.2 / (6.2% – 2.6%)

= NZ$2.4

dcf
dcf

The Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Scales as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.2%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Scales

Strength

  • Debt is not viewed as a risk.

Weakness

  • Earnings declined over the past year.

  • Dividend is low compared to the top 25% of dividend payers in the Food market.

  • Expensive based on P/E ratio and estimated fair value.

Opportunity

  • Annual earnings are forecast to grow faster than the New Zealander market.

Threat

  • Dividends are not covered by earnings.

Looking Ahead:

Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Can we work out why the company is trading at a premium to intrinsic value? For Scales, we've put together three further aspects you should look at:

  1. Risks: Be aware that Scales is showing 2 warning signs in our investment analysis , you should know about...

  2. Future Earnings: How does SCL's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every New Zealander stock every day, so if you want to find the intrinsic value of any other stock just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.